The global Specialty Pharmaceuticals Market is at the vanguard of healthcare innovation, stirred by cutting-edge treatments, quick development, and evolving industry trends. The global market size increased by USD 280.7 billion in 2024 and is expecte
The US market expansion through the introduction of new products in the gastrointestinal, pain management, and digestive health division’s propelled the company's reported revenue of Rs. 620 crore, up 5% year over year
Indoco Remedies Ltd. has obtained final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application
US pharmaceutical giant Eli Lilly stepped up competition with rival Danish drugmaker Novo Nordisk on Wednesday by introducing its popular diabetes medication Mounjaro in the Indian market. KwikPen is a single patient use prefilled pen intended for on
Zydus Lifesciences, a leading Indian pharmaceutical, is preparing to launch semaglutide variants, the active ingredient in antidiabetic and weight-loss drugs, as the patent nears expiration in 2026. The firm is expected to invest over ?100...
Zydus Lifesciences reported its consolidated revenue of Rs 65,737 million for Q1 FY26, highlighting a 6 percent YoY increase, while net profit rose 3 percent to Rs 14,668 million. The company has a strong foundation and plays
Asian Institute of Nephrology and Urology (AINU), India’s largest single-speciality chain focused on Uro-Nephro care, marks a new milestone with the expansion of its flagship hospital in Banjara Hills, Hyderabad. The flagship hospital has a combined
Cosmo Pharmaceuticals N.V., a global leader in AI-powered healthcare and specialty pharmaceuticals, has renewed its multi-year manufacturing and supply agreement with Takeda for Mesalazine
Eli Lilly's weight loss drug Mounjaro has rocketed through the Indian pharma market, quickly surging to ?100 crore in the first four months of launch, according to PharmaTrac data. Mounjaro sales were already just shy of ?50 crore for July alone...
India's pharmaceutical and medical device supply chain is on the brink of crisis as confusion surrounding the Ministry of Steel's recent mandate raises questions about the availability of critical components including surgical blades, needles, and...